UNC-Chapel Hill, GSK partner to find cure for HIV/AIDS

The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and healthcare company with a legacy of success in developing treatments for HIV, today announced the creation of the dedicated HIV Cure center and a jointly…

Experimental AIDS Vaccine Targets Hidden Virus

WebMD News from HealthDay By Randy Dotinga, HealthDay Reporter WEDNESDAY, April 29, 2015 (HealthDay News) — Preliminary research suggests that an AIDS vaccine in development can ramp up the body’s immune system, boosting the response to medications HIV-positive patients take. Years of research will be required to confirm that the vaccine works, and researchers don’t…